Screening methods for compounds useful in the regulation of body weight
US5932779A · kind A · utility
10Cited by
0References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 8, 1997 |
| Grant date | Aug 3, 1999 |
| Priority date | — |
| Expiry date | Jan 8, 2017 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2500/00
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present invention relates to drug screening assays, and diagnostic and therapeutic methods for the treatment of body weight disorders, such as obesity, anorexia and cachexia, utilizing the melanocortin 4-receptor (MC4-R) as the target for intervention. The invention also relates to compounds that modulate the activity or expression of the MC4-R, and the use of such compounds in the treatment of body weight disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.